Status:

COMPLETED

Phenylketonuria and Hyperphenylalaninemia Nutrition Study

Lead Sponsor:

University of Zurich

Conditions:

Phenylketonuria (PKU) and Hyperphenylalaninemia

Eligibility:

All Genders

16+ years

Brief Summary

The mainstay of PKU treatment is a low-phenylalanine diet (i.e restriction of natural protein), and supplementation with a protein substitute (a mixture of amino acids free from phenylalanine, also co...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • PKU (Phenylketonuria) or hyperphenylalaninemia
  • male or female, minimum age 16y
  • signed informed consent
  • Exclusion criteria:
  • \- patient who can not comply with the study protocol (e.g. unable to fill in questionnaires by themselves or a representative)

Exclusion

    Key Trial Info

    Start Date :

    June 1 2013

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2015

    Estimated Enrollment :

    30 Patients enrolled

    Trial Details

    Trial ID

    NCT01879995

    Start Date

    June 1 2013

    End Date

    July 1 2015

    Last Update

    February 8 2016

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    University Hospital Zurich, Division of Endocrinology, Diabetes and Clinical Nutrition

    Zurich, Canton of Zurich, Switzerland, 8091

    2

    University Children's Hospital

    Zurich, Switzerland, CH-8032